PPD
MAY 11, 2023
The global COVID-19 pandemic increased awareness of the importance of vaccine development — both for drug developers and the public. The speed at which COVID-19 vaccines were developed was remarkable, but like most newly developed vaccines, there was variation among who could receive the shots and when.
Alta Sciences
SEPTEMBER 13, 2023
Pain models can be important clinical tools to characterize a novel analgesic, and determine its potential effectiveness in models simulating varying pain stimuli. Here are four main pain models we use to assess treatments in clinical trials: 1. At Altasciences , we have extensive experience testing various pain models.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
OCTOBER 16, 2023
From the Beatson Institute for Cancer Research in Glasgow, to Edinburgh Drug Discovery in the University of Edinburgh’s Institute for Genetics and Cancer (IGC). At ELRIG’s Scottish Research and Drug Development Forum meeting, DDW’s Diana Spencer provided a snapshot of drug discovery in Scotland.
NIH Director's Blog: Drug Development
OCTOBER 11, 2022
Barry Sharpless, Scripps Research, La Jolla, CA, October 5, 2022 marked the second time that he’s received an early-morning congratulatory call from The Royal Swedish Academy of Sciences. 2001, 40 (11), 2004–2021 [2] A stepwise huisgen cycloaddition process: Copper(I)-catalyzed regioselective “Llgation” of azides and terminal alkynes.
The Pharma Data
DECEMBER 15, 2020
Such cooperation will rapidly expand the coverage of the drug product after its launch, providing professional pharmaceutical services to doctors and patients, and benefit more patients.” SH) was founded in Shenzhen on 2001, specializing in the research and development of novel small molecule drugs.
Conversations in Drug Development Trends
MAY 23, 2024
Regulatory Harmonization of Clinical Trials in the EU The EU-CTR repealed the Clinical Trial Directive 2001/20/EC (CTD) and national implementing legislation in the EU Member States on 31 January 2022.
Drug Discovery World
OCTOBER 7, 2022
Response-mode funding for drug discovery is being administered from the therapeutic division of the organisation for the first time, allowing for strategic build of a fully aligned portfolio stemming from the earliest stages of translational activity. . RA: How can the integration of industry and academia help streamline drug development?
Expert insights. Personalized for you.
52 
Let's personalize your content